CVS Health Corporation $CVS Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. cut its holdings in CVS Health Corporation (NYSE:CVS) by 1.0% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 66,104 shares of the pharmacy operator’s stock after selling 646 shares during the period. Securian Asset Management Inc.’s holdings in CVS Health were worth $4,560,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Harbor Asset Planning Inc. acquired a new position in shares of CVS Health in the 2nd quarter valued at about $30,000. Bell Investment Advisors Inc boosted its holdings in shares of CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the period. Roxbury Financial LLC lifted its position in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. ORG Partners LLC lifted its position in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the last quarter. Finally, Saudi Central Bank bought a new stake in CVS Health in the 1st quarter valued at about $34,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.22% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on CVS. Wolfe Research lifted their price objective on shares of CVS Health from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Monday, September 22nd. Cowen restated a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Leerink Partners boosted their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. Sanford C. Bernstein boosted their price target on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Finally, Morgan Stanley boosted their price target on shares of CVS Health from $82.00 to $89.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 14th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $82.57.

CVS Health Stock Up 0.7%

NYSE CVS opened at $83.06 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The company’s 50 day simple moving average is $74.70 and its 200 day simple moving average is $68.36. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $83.52. The company has a market capitalization of $105.34 billion, a P/E ratio of 23.20, a PEG ratio of 0.91 and a beta of 0.60.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.